82 FR 43238 - Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 177 (September 14, 2017)

Page Range		43238-43238
FR Document		2017-19500

Federal Register, Volume 82 Issue 177 (Thursday, September 14, 2017)

[Federal Register Volume 82, Number 177 (Thursday, September 14, 2017)]
[Notices]
[Page 43238]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-19500]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Pub. L. 92-463.

    Name of Committee: Safety and Occupational Health Study Section 
(SOHSS), National Institute for Occupational Safety and Health 
(NIOSH).
    Date: October 31-November 1, 2017.
    Time: 8:00 a.m.-5:00 p.m., CST.
    Place: The Wit Hotel, 201 North State Street, Chicago, Illinois 
60601.
    Agenda: The meeting will convene to address matters related to 
the conduct of Study Section business and for the study section to 
consider safety and occupational health-related grant applications.
    For Further Information Contact: Price Connor, Ph.D., NIOSH 
Health Scientist, CDC 2400 Executive Parkway, Atlanta, Georgia 
30345, (404) 498-2511, spc3@cdc.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-19500 Filed 9-13-17; 8:45 am]
 BILLING CODE 4163-18-P

43238 Federal Register / Vol. 82, No. 177 / Thursday, September 14, 2017 / Notices

ACTION: Notice of meeting. Service Act, immunization Place: The Wit Hotel, 201 North State
recommendations of the ACIP that have Street, Chicago, Illinois 60601.
SUMMARY: In accordance with section been approved by the Director of the Agenda: The meeting will convene to
10(a)(2) of the Federal Advisory Centers for Disease Control and address matters related to the conduct of
Committee Act, the Centers for Disease Prevention and appear on CDC Study Section business and for the study
Control and Prevention (CDC) immunization schedules must be section to consider safety and occupational
announces the following meeting of the health-related grant applications.
covered by applicable health plans.
Advisory Committee on Immunization For Further Information Contact: Price
Matters to be Considered: The agenda
Practices (ACIP). Connor, Ph.D., NIOSH Health Scientist, CDC
will include discussions on adult 2400 Executive Parkway, Atlanta, Georgia
This meeting is open to the public, immunization schedule, child/
limited only by the space available. 30345, (404) 498–2511, spc3@cdc.
adolescent immunization schedule,
Time will be available for public The Director, Management Analysis and
influenza vaccines, anthrax vaccine, Services Office, has been delegated the
comment. The public is welcome to Japanese encephalitis vaccines, hepatitis
submit written comments in advance of authority to sign Federal Register notices
vaccines, herpes zoster vaccines, human pertaining to announcements of meetings and
the meeting. Comments should be papillomavirus vaccines, mumps other committee management activities, for
submitted in writing by email to the vaccine, pneumococcal vaccines, both the Centers for Disease Control and
contact person listed below. The respiratory syncytial virus vaccine and Prevention and the Agency for Toxic
deadline for receipt is October 11, 2017. immunization safety update. A Substances and Disease Registry.
Written comments must include full recommendation vote is scheduled for
name, address, organizational Elaine L. Baker,
adult immunization schedule, child/
affiliation, email address of the speaker, adolescent immunization schedule, Director, Management Analysis and Services
topic being addressed and specific Office, Centers for Disease Control and
hepatitis vaccines and herpes zoster
comments. Written comments must not Prevention.
vaccines. A Vaccines for Children vote
exceed one single-spaced typed page is scheduled for hepatitis vaccines. [FR Doc. 2017–19500 Filed 9–13–17; 8:45 am]
with 1-inch margins containing all items Agenda items are subject to change as BILLING CODE 4163–18–P
above. Only those written comments priorities dictate.
received 10 business days in advance of The Director, Management Analysis
the meeting will be included in the and Services Office, has been delegated DEPARTMENT OF HEALTH AND
official record of the meeting. Public the authority to sign Federal Register HUMAN SERVICES
comments made in attendance must be notices pertaining to announcements of
no longer than 3 minutes and the person Centers for Disease Control and
meetings and other committee
giving comments must attend the public Prevention
management activities, for both the
comment session at the start time listed Centers for Disease Control and Notice of Closed Meeting
on the agenda. Time for public Prevention and the Agency for Toxic
comments may start before the time Substances and Disease Registry. In accordance with Section 10(a)(2) of
indicated on the agenda. The meeting
Elaine L. Baker, the Federal Advisory Committee Act
will be webcast live via the World Wide
Director, Management Analysis and Services (Pub. L. 92–463), the Centers for Disease
Web; for instructions and more
Office, Centers for Disease Control and Control and Prevention (CDC)
information on ACIP please visit the
Prevention. announces the following meeting.
ACIP Web site: http://www.cdc.gov/
vaccines/acip/index.html. [FR Doc. 2017–19497 Filed 9–13–17; 8:45 am] The meeting will be closed to the
DATES: The meeting will be held on BILLING CODE 4163–18–P public in accordance with provisions set
October 25, 2017, 8:00 a.m. to 6:00 p.m., forth in Section 552b(c)(4) and (6), Title
EDT, and October 26, 2017 8:00 a.m. to 5 U.S.C., and the Determination of the
DEPARTMENT OF HEALTH AND Director, Management Analysis and
3:15 p.m. EDT.
HUMAN SERVICES Services Office, CDC, pursuant to Public
ADDRESSES: 1600 Clifton Road NE.,
Law 92–463.
Atlanta, GA 30329, CDC, Tom Harkin Centers for Disease Control and
Global Communications Center, Kent Prevention Name of Committee: Disease, Disability,
‘Oz’ Nelson Auditorium. and Injury Prevention and Control Special
Notice of Closed Meeting Emphasis Panel (SEP)—PAR 13–129, NIOSH
FOR FURTHER INFORMATION CONTACT:
Member Conflict Special Emphasis Panel.
Stephanie Thomas, ACIP Committee In accordance with Section 10(a)(2) of Date: October 25, 2017.
Management Specialist, CDC, NCIRD; the Federal Advisory Committee Act Time: 1:00 p.m.–5:00 p.m., EDT.
email: ACIP@cdc.gov. (Pub. L. 92–463), the Centers for Disease Place: Teleconference.
SUPPLEMENTARY INFORMATION: Control and Prevention (CDC) Agenda: The meeting will include the
Purpose: The committee is charged announces the following meeting. initial review, discussion, and evaluation of
with advising the Director, CDC, on the The meeting will be closed to the applications received in response to PAR 13–
use of immunizing agents. In addition, public in accordance with provisions set 129, NIOSH Member Conflict Special
under 42 U.S.C. 1396s, the committee is Emphasis Panel.
forth in Section 552b(c)(4) and (6), Title
mandated to establish and periodically For FuRther Information Contact: Nina
5 U.S.C., and the Determination of the Turner, Ph.D. Scientific Review Officer, CDC,
asabaliauskas on DSKBBXCHB2PROD with NOTICES

review and, as appropriate, revise the Director, Management Analysis and 1095 Willowdale Road, Morgantown, West
list of vaccines for administration to Services Office, CDC, pursuant to Pub. Virginia 26506, (304) 285–5976, nxt2@
vaccine-eligible children through the L. 92–463. cdc.gov.
Vaccines for Children (VFC) program, The Director, Management Analysis and
Name of Committee: Safety and
along with schedules regarding dosing Occupational Health Study Section (SOHSS), Services Office, has been delegated the
interval, dosage, and contraindications National Institute for Occupational Safety authority to sign Federal Register notices
to administration of vaccines. Further, and Health (NIOSH). pertaining to announcements of meetings and
under provisions of the Affordable Care Date: October 31–November 1, 2017. other committee management activities, for
Act, section 2713 of the Public Health Time: 8:00 a.m.–5:00 p.m., CST. both the Centers for Disease Control and

VerDate Sep<11>2014 16:41 Sep 13, 2017 Jkt 241001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1

Document Created: 2017-09-13 23:49:35
Document Modified: 2017-09-13 23:49:35

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 31-November 1, 2017.
Contact		Price Connor, Ph.D., NIOSH Health Scientist, CDC 2400 Executive Parkway, Atlanta, Georgia 30345, (404) 498-2511, [email protected]
FR Citation		82 FR 43238

82 FR 43238 - Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 82, Issue 177 (September 14, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention